Brief: Basilea Announces Distribution Agreement With JSC Lancet For Antibiotic Zevtera® (Ceftobiprole)

Basilea Pharmaceutica AG, Allschwil

14/07/2021 06:16

July 14 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * BASILEA ANNOUNCES DISTRIBUTION AGREEMENT WITH JSC LANCET
FOR
ANTIBIOTIC ZEVTERA® (CEFTOBIPROLE) COVERING RUSSIA AND THE
EURASIAN ECONOMIC UNION
    * ANNOUNCES DISTRIBUTION AGREEMENT WITH JSC LANCET FOR
ANTIBIOTIC
ZEVTERA® (CEFTOBIPROLE) COVERING RUSSIA AND EURASIAN ECONOMIC
UNION
    * JSC LANCET IS GRANTED EXCLUSIVE RIGHT TO REGISTER,
DISTRIBUTE
AND COMMERCIALIZE ZEVTERA IN LICENSE TERRITORY
    * WILL RECEIVE AN UPFRONT PAYMENT AND BE ELIGIBLE FOR SALES
MILESTONE PAYMENTS
    * BASILEA WILL SUPPLY JSC LANCET WITH PRODUCT AT A TRANSFER
PRICE

Source text for Eikon:  ID:nGNE7HYcfH 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))